newsfilter
← Latest News
GlobeNewswire·

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference

HANOVER, Md., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies